Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

ASHRAF MOHAMED, MD, PLC

NPI: 1184741407 · DEARBORN, MI 48126 · Pain Medicine (Psychiatry & Neurology) Physician · NPI assigned 03/23/2007

$703K
Total Medicaid Paid
22,844
Total Claims
22,492
Beneficiaries
28
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialMOHAMED, ASHRAF (PRESIDENT)
NPI Enumeration Date03/23/2007

Related Entities

Other providers sharing the same authorized official: MOHAMED, ASHRAF

ProviderCityStateTotal Paid
BLUE RIDGE MEDICAL TRANSPORTATION, INC SALEM VA $521K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 6,709 $172K
2019 6,415 $148K
2020 3,065 $81K
2021 2,351 $99K
2022 1,841 $92K
2023 1,265 $64K
2024 1,198 $47K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
64493 3,482 3,445 $349K
64494 3,459 3,424 $171K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 1,022 1,005 $71K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 1,437 1,424 $56K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 716 706 $24K
80305 2,003 1,973 $7K
99441 547 536 $7K
J3490 Unclassified drugs 1,932 1,845 $6K
81002 1,785 1,753 $4K
27096 32 31 $2K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 243 239 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 2,822 2,791 $1K
64635 20 19 $703.98
64636 18 17 $386.08
J1885 Injection, ketorolac tromethamine, per 15 mg 585 583 $359.66
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 238 234 $53.31
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 367 360 $0.00
4004F 105 104 $0.00
G9744 Patient not eligible due to active diagnosis of hypertension 66 65 $0.00
G9584 Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy 579 571 $0.00
G9622 Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method 65 65 $0.00
G9561 Patients prescribed opiates for longer than six weeks 213 207 $0.00
G8730 Pain assessment documented as positive using a standardized tool and a follow-up plan is documented 266 265 $0.00
G9578 Documentation of signed opioid treatment agreement at least once during opioid therapy 85 85 $0.00
G9562 Patients who had a follow-up evaluation conducted at least every three months during opioid therapy 32 32 $0.00
G9583 Patients prescribed opiates for longer than six weeks 171 170 $0.00
S0020 Injection, bupivicaine hydrochloride, 30 ml 380 373 $0.00
1036F 174 170 $0.00